Compazine and Ecchymosis - a phase IV clinical study of FDA data

Summary:

Ecchymosis is reported as a side effect among people who take Compazine (prochlorperazine maleate), especially for people who are male, 60+ old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Ecchymosis when taking Compazine. It is created by eHealthMe based on reports of 13,599 people who have side effects when taking Compazine from the FDA, and is updated regularly.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

What is Ecchymosis?

Ecchymosis (a discoloration of the skin resulting from bleeding underneath) is found to be associated with 1,015 drugs and 1,085 conditions by eHealthMe. Check the latest studies of Ecchymosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

13,599 people reported to have side effects when taking Compazine.
Among them, 21 people (0.15%) have Ecchymosis.

Among these 21 people:

What is the gender of people who have Ecchymosis when taking Compazine? *

female: 40 %
male: 60 %

What is the age of people who have Ecchymosis when taking Compazine? *

What are other drugs people take besides Compazine? *

What are other side effects people have besides Ecchymosis? *

Fall: 12 people, 57.14%
Pain: 11 people, 52.38%
Stress And Anxiety: 11 people, 52.38%
Diarrhea: 11 people, 52.38%
Death: 11 people, 52.38%
Anaemia (lack of blood): 10 people, 47.62%
Dyspnea (difficult or laboured breathing): 10 people, 47.62%
Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 47.62%
Pleural Effusion (water on the lungs): 9 people, 42.86%
Weakness: 9 people, 42.86%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 23.81%
Anaemia (lack of blood): 3 people, 14.29%
Metastases To Bone (cancer spreads to bone): 2 people, 9.52%
Breast Cancer Female: 2 people, 9.52%
Tumor Lysis Syndrome: 1 person, 4.76%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 4.76%
Bone Disorder: 1 person, 4.76%
Brain Neoplasm Malignant (brain cancer tumour): 1 person, 4.76%
Breast Cancer: 1 person, 4.76%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Compazine and have Ecchymosis?

- Check whether Ecchymosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Compazine:

Compazine (13,646 reports)

Ecchymosis treatments and more:

Ecchymosis (13,357 reports)

Browse all side effects of Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ecchymosis:

Ecchymosis (1,015 drugs)

Browse all the conditions that are associated with Ecchymosis:

Ecchymosis (1,085 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prochlorperazine maleate (the active ingredients of Compazine) and Compazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.